Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.

Author/creator	United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations
Format	Electronic and Book
Publication Info	Washington : U.S. Government Printing Office, 1998.
Description	1 online resource (iii, 152 pages) : illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo119756
Subject(s)	United States. Food and Drug Administration--Rules and practice. Off-label drug use--United States. Drug approval--United States. Drugs--Labeling --Government policy --United States. Drugs--Side effects --United States. Off-Label Use

General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (govinfo, viewed May 2, 2019).
Issued in other form	Print version: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations. Off-label drug use and FDA review of supplemental drug applications
Genre/form	Legislative hearings.
GPO item number	1016-C (online)
Govt. docs number	Y 4.G 74/7:OF 2/6

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	Access Content Online	✔ Available